Cleo Diagnostics Ltd (ASX:COV)
Australia flag Australia · Delayed Price · Currency is AUD
0.3800
-0.0200 (-5.00%)
At close: Jul 31, 2025, 4:00 PM AEST

Cleo Diagnostics Company Description

Cleo Diagnostics Ltd, a medical diagnostics and devices company, focuses on the development and commercializing of non-invasive blood tests to detect ovarian cancer in Australia.

The company provides CleoDX pre-surgical triage tests which measures a combination of biomarkers in serum to provide an accurate determination of malignancy risk prior to surgical referral.

It also focuses on developing and testing intellectual property and patents. The company was incorporated in 2021 and is based in Melbourne, Australia.

Cleo Diagnostics Ltd
CountryAustralia
Founded2021
IndustryMedical Devices
SectorHealthcare
CEORichard Allman

Contact Details

Address:
480 Collins Street
Melbourne, 3000
Australia
Phone61 3 9614 0600
Websitecleodx.com

Stock Details

Ticker SymbolCOV
ExchangeAustralian Securities Exchange
Stock TypeCommon Stock
Fiscal YearJuly - June
Reporting CurrencyAUD
ISIN NumberAU0000288045
SIC Code2835

Key Executives

NamePosition
Dr. Richard Allman Ph.D.Chief Executive Officer and Executive Director
Dr. Andrew N. StephensChief Scientific Officer and Executive Director
Prof. Thomas William JoblingLead Medical Advisor and Independent Non-Executive Director
Nathan HodgsonHead of Operations
Dayna LoucaHead of Corporate Development
Pauline M. Moffatt AAICD, B.Com., BCom, FGIACompany Secretary